US 9006283
Methods of modifying amyloid β oligomers using non-peptidic compounds
granted A61KA61K31/381A61K31/41
Quick answer
US patent 9006283 (Methods of modifying amyloid β oligomers using non-peptidic compounds) held by Acumen Pharmaceuticals, Inc. expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acumen Pharmaceuticals, Inc.
- Grant date
- Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/381, A61K31/41, A61K31/415, A61K9/0019